TickerFactsScreenerDevelopers

NEUROCRINE BIOSCIENCES INC (NBIX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$53.09M2010: $49.94M2011: -$698.0K2012: -$35.29M2013: -$29.61M2016: -$106.18M2017: -$94.33M2018: $101.40M2019: $147.00M2020: $228.50M2021: $256.50M2022: $339.40M2023: $389.90M2024: $595.40M2025: $782.70M$782.70M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$782.70M+31.5%
2024$595.40M+52.7%
2023$389.90M+14.9%
2022$339.40M+32.3%
2021$256.50M+12.3%
2020$228.50M+55.4%
2019$147.00M+45.0%
2018$101.40M+207.5%
2017-$94.33M+11.2%
2016-$106.18M—
2013-$29.61M+16.1%
2012-$35.29M-4956.4%
2011-$698.0K-101.4%
2010$49.94M+194.1%
2009-$53.09M—